The American Cancer Society recommends that asymptomatic males, who are expected to have a 10-year life expectancy, be offered the opportunity to make an informed decision with their healthcare provider about PCa screening with prostate-specific antigen (PSA) testing [2]. Here, KLK3 is linked to posterior cortical atrophy.